与贝尔祖蒂芬治疗转移性细胞癌相关的复发性黄斑胀
1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, USA.
一个案例研究表明,贝尔祖提凡治疗的囊性黄斑胀 (CME) 在停止服用该药物后迅速逆转. 当重新开始使用贝尔祖提凡时,CME复发,这表明需要对接受这种治疗的患者进行眼睛监测.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 贝尔祖提方是一种低氧诱导因子-2α (HIF-2α) 抑制剂,用于治疗转移性细胞癌.
- 针对性癌症治疗的眼部副作用需要仔细监测.
研究的目的:
- 为了记录一个与贝尔祖蒂芬治疗相关的快速可逆的囊性黄斑 (CME) 病例.
- 强调在接受HIF-2α抑制剂治疗的患者眼科监测的重要性.
主要方法:
- 一个患者在贝尔祖提凡治疗期间出现视觉变化的单一案例被追溯审查.
- 分析了临床表现,治疗过程和眼科发现.
主要成果:
- 一名70岁的男性患有转移性细胞癌,在开始使用贝尔祖提凡后的两周内出现了症状性CME.
- 在停止使用贝尔祖提凡后的一周内,CME 消失,在重新开始使用较低剂量时复发.
结论:
- 本报告详细介绍了在临床环境中与贝尔祖提凡相关的首例快速可逆的CME.
- 眼科监测对于接受贝尔祖提凡或类似的缺氧诱导因子-2α抑制剂的患者至关重要,这是由于潜在的眼睛毒性.
更多相关视频
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
相关概念视频
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Gene Therapy
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
